Ciprofloxacin hydrochloride-loaded glyceryl monostearate nanoparticle: factorial design of Lutrol F68 and Phospholipon 90G

References

• Ahlin P, Kristl J, Smid-Korbar J. Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions. Acta Pharm 1998; 48: 259–67
   Google Scholar
• Ahmad H, Yaseen M. Application of a chemical group contribution technique for calculating solubility parameters of polymers. Polymer Eng Sci 1979; 19: 858–63
   Web of Science ®Google Scholar
• Banker GS, Rhodes CT. Modern pharmaceutics. Informa HealthCare, New York 2002
   Google Scholar
• Barton AFM. CRC handbook of solubility parameters and other cohesion parameters. CRC, Florida 1991
   Google Scholar
• Barton AFM. Applications of solubility parameters and other cohesion parameters in polymer science and technology. Pure Appl Chem 1985; 57: 905–12
   Web of Science ®Google Scholar
• Bordes C, Fréville V, Ruffin E, Marote P, Gauvrit JY, Briançon S, Lantéri P. Determination of poly(-caprolactone) solubility parameters: Application to solvent substitution in a microencapsulation process. Int J Pharm, 2010;383:236–43.
   Google Scholar
• Cavalli R, Caputo O, Marengo E, Pattarino F, Gasco MR. The effects of components of microemulsions on both size and crystalline structure of solid lipid nanoparticles (SLN) containing a series of model molecules. Pharmazie 1998; 53: 392–96
   Web of Science ®Google Scholar
• Charoo NA, Kohli K, Ali A, Anwer A. Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies. Drug Dev Ind Pharm 2003; 29(2)215–21
   PubMed Web of Science ®Google Scholar
• Chatzaeiaoannou TP. Quantitative calculations in pharmaceutical practice and research. VCH Publishers, New York 1993
   Google Scholar
• Clausse M. Dielectric Properties of emulsions and related systems. Encyclopedia of emulsion technology, P Becher. Marcel Dekker Inc., New York 1983; 1: 481–715
   Google Scholar
• Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Biopharm 2001; 13: 123–33
   Web of Science ®Google Scholar
• Dillena K, Vandervoorta J, Mooterb G, Verheydenb L, Ludwig A. Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int J Pharm 2004; 275: 171–87
   PubMedGoogle Scholar
• Egger SF, Ruckhofer J, Alzner E, Hell M, Hitz W, Grabner G. In vitro susceptibilities to topical antibiotics of bacteria isolated from the surface of clinically symptomatic eyes. Ophthalmic Res 2001; 33: 117–20
   PubMed Web of Science ®Google Scholar
• Ghebremeskel AN, Vemavarapu C, Lodaya M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: Selection of polymer-surfactant combinations using solubility parameters and testing the processability. Int J Pharm 2007; 328: 119–29
   PubMed Web of Science ®Google Scholar
• Gohel MC, Panchal MK, Jogani VV. Novel mathematical method for quantitative expression of deviation from the Higuchi model. AAPS PharmSciTech 2000; 1: 43–8
   Google Scholar
• Hansen CM. Hansen solubility parameters: A user's handbook. CRC, Florida 2007
   Google Scholar
• Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. Physico-chemical stability of colloidal lipid particles. Biomaterials, 2003;24:4283–300.
   Google Scholar
• Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963; 52: 1145–9
   PubMed Web of Science ®Google Scholar
• Komatsu H, Kitajima A, Okada S. Pharmaceutical characterization of commercially available intravenous fat emulsions: estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy. Chem Pharm Bull 1995; 43: 1412–15
   PubMed Web of Science ®Google Scholar
• Li X, Nies S, Kong J, Li N, Jue C, Pana W. A controlled release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm 2008; 363: 177–82
   PubMed Web of Science ®Google Scholar
• Magdassi S, Siman-Tov A. Formation and stabilization of perfluorocarbon emulsions. Int J Pharm 1990; 59: 69–72
   Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 2001; 47: 165–96
   PubMed Web of Science ®Google Scholar
• Mishra GP, Bagui M, Tamboli V, Mitra AK, Recent applications of liposomes in ophthalmic drug delivery. J Drug Deliv, 2011;2011:1–14
   Google Scholar
• Morel S, Ugazio E, Cavalli R, Gasco MR. Thymopentin in solid lipid nanoparticles. Int J Pharm 1996; 132: 259–61
   Web of Science ®Google Scholar
• Muller RH. Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. Int J Pharm 1996; 138: 85–94
   Web of Science ®Google Scholar
• Muller RH. Solid lipid nanoparticles: Phagocytic uptake, in vitro cytotoxicity and in vitro biodegradation. Pharm Ind 1999; 61: 564–9
   Web of Science ®Google Scholar
• Muller RH, Maaben S, Weyhers H, Mehnert W. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J Drug Target 1996; 4: 161–70
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – A review of the state of the art. Eur J Pharm Biopharm 2000; 50: 161–77
   PubMed Web of Science ®Google Scholar
• Muller RH, Ruhl D, Runge S, Schulze-Forster K, Mehnert W. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm Res 1997; 14: 458–62
   PubMed Web of Science ®Google Scholar
• Müller RH, Wallis K, Tröster S, Kreuter J. In vitro characterization of poly (methyl-methaerylate) nanoparticles and correlation to their in vivo fate. J Contr Release 1992; 20: 237–46
   Web of Science ®Google Scholar
• Olbrich C, Gessner A, Schroder W, Kayser O, Muller RH. Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene – Cytotoxicity testing and mouse serum adsorption. J Cont Release 2004a; 96: 425–35
   PubMed Web of Science ®Google Scholar
• Olbrich C, Muller RH, Tabatt K, Kayser O, Schulze C, Schade R. Stable biocompatible adjuvants: a new type of adjuvant based on solid lipid nanoparticles: a study on cytotoxicity, compatibility and efficacy in chicken. Altern Lab Anim 2002; 30: 443–58
   PubMed Web of Science ®Google Scholar
• Olbrich C, Scholer N, Tabatt K, Kayser O, Muller RH. Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages – Impact of phagocytosis on viability and cytokine production. J Pharm Pharmacol 2004b; 56: 883–91
   PubMed Web of Science ®Google Scholar
• Pandita D, Ahuja A, Lather V, Dutta T, Velpandian T, Khar R. Development, characterization and in vitro assessement of stearylamine-based lipid nanoparticles of paclitaxel. Pharmazie 2011; 66: 171–7
   PubMed Web of Science ®Google Scholar
• Reithmeier H, Herrmann J, Gopferich A. Lipid microparticles as a parenteral controlled release device for peptides. J Contr Release 2001; 73: 339–50
   PubMed Web of Science ®Google Scholar
• Reza M, Quadir MA, Haider SS. Development of theophylline sustained release dosage form based on kollidon SR. Pak J Pharm Sci 2002; 15: 63–70
   PubMed Web of Science ®Google Scholar
• Roberts R, Rowe R. The solubility parameter and fractional polarity of microcrystalline cellulose as determined by mechanical measurement. Int J Pharm 1993; 99: 157–64
   Web of Science ®Google Scholar
• Schubert M, Muller-Goymann C. Characterisation of surface-modified solid lipid nanoparticles (SLN): Influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm 2005; 61: 77–86
   PubMed Web of Science ®Google Scholar
• Schubert MA, Harms M, Muller-Goymann CC. Structural investigations on lipid nanoparticles containing high amounts of lecithin. Eur J Pharm 2006; 27: 226–36
   Google Scholar
• Schwarz C. Solid lipid nanoparticles (SLN) for controlled drug delivery II. Drug incorporation and physicochemical characterization. J Microencapsul 1999; 16: 205–13
   PubMed Web of Science ®Google Scholar
• Shi L, Li Z, Yu L, Jia H, Zheng L. Effects of surfactants and lipids on the preparation of solid lipid nanoparticles using double emulsion method. Journal of Disper Sci Tech 2011; 32: 254–9
   Web of Science ®Google Scholar
• Sinha VR, Srivastava S, Goel H, Jindal V. Solid lipid nanoparticles (SLN's) – Trends and implications in drug targeting. Int J Adv Pharmaceut Sci 2010; 1: 212–38
   Google Scholar
• Swardrick J. Encyclopedia of pharmaceutical technology. Informa Healthcare, New York 2007
   Google Scholar
• Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique. Int J Pharm 2003; 257: 153–60
   PubMed Web of Science ®Google Scholar
• van Krevelen DW, Hoftyzer P. Properties of polymers. Elsevier Publishing Company, New York 1976
   Google Scholar
• Vaughan C. Using solubility parameters in cosmetics formulation. J Soc Cosmet Chem 1985; 36: 319–33
   Web of Science ®Google Scholar
• Verheyen S, Augustijns P, Kinget R, Van den Mooter G. Determination of partial solubility parameters of five benzodiazepines in individual solvents. Int J Pharm, 2001;228:199–207.
   Google Scholar
• Wang Y, Deng Y, Mao S, Jin S, Wang J, Bi D. Characterization and body distribution of -elemene solid lipid nanoparticles (SLN). Drug Dev Ind Pharm 2005; 31: 769–78
   PubMed Web of Science ®Google Scholar
• Westesen K, Siekmann B. Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int J Pharm 1997; 151: 35–45
   Web of Science ®Google Scholar
• Wiacek AE. Electrokinetic properties of n-tetradecane/lecithin solution emulsions. Colloid Surface Physicochem Eng Aspect 2007; 293: 20–7
   Web of Science ®Google Scholar
• Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev 1995; 16: 61–73
   Web of Science ®Google Scholar
• Yassin AEB, Anwer M, Mowafy HA, El-Bagory I, Bayomi M, Alsarra I. Optimization of 5-fluorouracil solid-lipid nanoparticles: A preliminary study to treat colon cancer. Int J Med Sci, 2010;7(6):398–408.
   Google Scholar
• Zimmermann E, Müller RH. Electrolyte-and pH-stabilities of aqueous solid lipid nanoparticle (SLN (TM)) dispersions in artificial gastrointestinal media. Eur J Pharm Biopharm 2001; 52: 203–10
   PubMed Web of Science ®Google Scholar